NEUROLITE
Google image searchProduct monograph
Active ingredient
bicisate dihydrochloride, 0.9 MG/VIAL
DIN: 02327848
Dosage form(s): KIT, POWDER FOR SOLUTION
Route(s) of administration: INTRAVENOUS
Schedule: Schedule C
Company: LANTHEUS MI CANADA INC
Date: 04-SEP-2018
ATC:
